Analysis of the U.S. Cancer Biomarker Testing Market
Analysis of the U.S. Cancer Biomarker Testing Market
Targeted Sequencing of Tumor Mutations is on the Horizon
RELEASE DATE
29-Jun-2012
29-Jun-2012
REGION
North America
North America
Research Code: NB1D-01-00-00-00
SKU: HC02229-NA-MR_07963
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
HC02229-NA-MR_07963
Description
This research service analyzes the U.S. cancer biomarker testing market from 2009 to 2017. Topics include an overview of the market, along with definitions, metrics, drivers, and restraints. Also offered is an evaluation of ongoing technology trends and major market competitors and their corresponding market shares and product offerings. Based on this analysis, revenue forecasts and growth rates are projected for each segment of the market. This study also provides cancer epidemiology trends, voice-of-customer research on oncologists, and the challenges and strategies for cancer biomarker validation.
Table of Contents
Research Service
- Executive Summary
- Market Overview
Total U.S. Cancer Biomarker Testing Segment
- Industry Trends
- External Challenges: Drivers and Restraints
- Forecasts and Trends
- Market Share and Competitive Analysis
- Product Analysis
- Epidemiology
- Voice-of-Customer Research
- Cancer Biomarker Validation Challenges and Strategies
Molecular Cancer Biomarker Testing Segment Breakdown
- Forecast and Trends
Traditional Cancer Biomarker Testing Segment Breakdown
- Forecasts and Trends
The Last Word
- Conclusions and Implications
Appendix
- Appendix
Popular Topics
This research service analyzes the U.S. cancer biomarker testing market from 2009 to 2017. Topics include an overview of the market, along with definitions, metrics, drivers, and restraints. Also offered is an evaluation of ongoing technology trends and major market competitors and their corresponding market shares and product offerings. Based on this analysis, revenue forecasts and growth rates are projected for each segment of the market. This study also provides cancer epidemiology trends, voice-of-customer research on oncologists, and the challenges and strategies for cancer biomarker validation.
No Index | Yes |
---|---|
Podcast | No |
Author | Winny Tan |
Industries | Healthcare |
WIP Number | NB1D-01-00-00-00 |
Is Prebook | No |